THE EUROPEAN DRUG DISCOVERY FORUM 2025
24-25 NOVEMBER, 2025 | BERLIN, GERMANY
Accelerating the journey from lab to clinic!
24-25 NOVEMBER, 2025
NH BERLIN ALEXANDERPLATZ
BERLIN, GERMANY
Overview
Drug discovery plays a critical role in improving global health by identifying and developing new therapies to combat diseases, extend life expectancy, and enhance quality of life. In an era of rapidly evolving science and pressing medical challenges, collaboration and innovation have never been more essential, therefore our goal is to bring together leading voices from academia, industry, and research to share insights, innovations, and breakthroughs shaping the future of drug discovery.
The first day we will focus on the role of Artificial Intelligence diving into topics like AI and collective intelligence and we will be able to learn more about Boehringer Ingelheims AI applications.
On the second day, drug design and drug discovery will have the main role with titles like Fragment-based drug design or Engineering polymer systems for controlled and targeted drug discovery.
Join us in Berlin on the 24th and 25th of November as we explore cutting-edge approaches, novel technologies, and collaborative strategies that are accelerating the journey from lab to clinic. We look forward to meet you at the Drug discovery conference!
#masterclass #qaqchub #pharma #qualityassurance #qualitycontrol #pharmaconference #drugdiscovery #ai #toxicology #riskassessment #patientengagement #glceurope #globalleadingconferences

Fraunhofer ITMP
Germany

Bristol Myers Squibb
United Kingdom

Boehringer Ingelheim
Germany

Bioinformatics Institute (A*STAR)
Singapore

GSK
United Kingdom

Sanof
France

Manfred Fischer Consulting
Germany

Universidade do Algarve
Portugal

Bayer
Germany

Roche
Switzerland

Novo Nordisk
Denmark

Novartis
Switzerland

Bayer
Türkiye